查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1231759

预测诊断的全球市场

Predictive Diagnostics
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 276 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预测诊断的全球市场2030年前将达到47亿美元

在COVID-19后改变的商务环境中，2022年19亿美元的预测诊断的全球市场2030年前将达到47亿美元的规模，在2022年～2030年预计将以12％的年复合成长率增长。

美国市场估算为5亿6,110万美元估计，中国则将以年复合成长率11.1％增长

美国的预测诊断市场在2022年估算为5亿6,110万美元。作为世界第2大经济大国的中国，在2022年～2030年复合成长率预计将为11.1％，2030年达到8亿480万美元的市场规模。其他热门的地区市场有日本和加拿大，在2022年～2030年预计将各以10.6％和9.4％的速度成长。在欧洲市场中，德国预计将以年复合成长率9.2％成长。

调查对像企业范例

  • Abbott Molecular
  • Almac Group Ltd.
  • Ambry Genetics Corp.
  • BioGenex
  • Epistem Ltd.
  • Epistem Ltd.
  • MDxHEALTH Inc.
  • Myriad Genetics Inc.
  • OPKO Health, Inc.
  • Prometheus Laboratories Inc.
  • QIAGEN N.V.

目录

第1章 调查手法

第2章 摘要整理

  • 市场概要
  • 主要企业
  • 市场趋势与推动因素
  • 全球市场预测

第3章 市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲
  • 亚太地区
  • 全球其他地区

第4章 竞争

简介目录
Product Code: MCP-7843

What`s New for 2023?

»Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.

»Global competitiveness and key competitor percentage market shares

» Market presence across multiple geographies - Strong/Active/Niche/Trivial

»Online interactive peer-to-peer collaborative bespoke updates

»Access to our digital archives and MarketGlass Research Platform

»Complimentary updates for one year

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Predictive Diagnostics Market to Reach $4.7 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Predictive Diagnostics estimated at US$1.9 Billion in the year 2022, is projected to reach a revised size of US$4.7 Billion by 2030, growing at a CAGR of 12% over the period 2022-2030.

The U.S. Market is Estimated at $561.1 Million, While China is Forecast to Grow at 11.1% CAGR

The Predictive Diagnostics market in the U.S. is estimated at US$561.1 Million in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$804.8 Million by the year 2030 trailing a CAGR of 11.1% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 10.6% and 9.4% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 9.2% CAGR.

Select Competitors (Total 47 Featured):

  • Abbott Molecular
  • Almac Group Ltd.
  • Ambry Genetics Corp.
  • BioGenex
  • Epistem Ltd.
  • Epistem Ltd.
  • MDxHEALTH Inc.
  • Myriad Genetics Inc.
  • OPKO Health, Inc.
  • Prometheus Laboratories Inc.
  • QIAGEN N.V.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • A Curtain Raiser
    • Recent Market Activity
    • Predictive Diagnostics - A Key Segment of Genetic Testing
    • Outlook for Predictive Diagnostics Market
    • Growing Popularity of Multi-gene Panels in Clinical Cancer Genetics
    • Clinical Characteristics of Moderate-High Penetrance Genes Other than BRCA1/2
    • Challenges Associated with Multigene-Panel Testing
    • Next-Generation Sequencing - A Giant Leap in Genome Sequencing
    • Genes Included in NGS Panels
    • Predictive Diagnostics - Global Key Competitors Percentage Market Share in 2022 (E)
    • Impact of Covid-19 and a Looming Global Recession
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
  • 2. FOCUS ON SELECT PLAYERS
    • Abbott Molecular (USA)
    • Almac Group Ltd. (Ireland)
    • Ambry Genetics Corporation (USA)
    • BioGenex (USA)
    • Epistem Ltd. (UK)
    • F. Hoffmann-La Roche Ltd. (Switzerland)
    • Genomic Health, Inc. (USA)
    • MDxHEALTH, Inc. (USA)
    • Myriad Genetics, Inc. (USA)
    • OPKO Health, Inc. (USA)
    • Prometheus Laboratories Inc. (USA)
    • Proteomics International Laboratories Ltd (Australia)
    • QIAGEN N.V. (The Netherlands)
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence and Prevalence of CDDs: A Major Growth Driver
    • Increasing Cancer Disease Burden Drives the Demand for Predictive Diagnostics
    • Incidence of Neurodegenerative Diseases Increasing
    • Alzheimer's Disease
    • Huntington's Disease
    • Parkinson's Disease
    • Ballooning Global Population Offers Significant Growth Opportunities
    • Predictive Diagnostics Enable Higher Life Expectancy
    • Widening of Insurance Coverage for Hereditary Cancer Testing
    • Discovery of Novel Biomarkers - Crucial to Predictive Diagnostics
    • Genomic Research Remains Confined to Fundamental Research
    • Unresolved Issues Hamper Widespread Implementation of Genetic Testing for Monogenetic Disease
    • Dearth of Genetic Counselors - A Major Hurdle for the Predictive Genetic Testing
    • Framework for Validation, Regulation, and Ethical Issues - The Need of the Hour
    • Prospects for Predictive Genetic Diagnostics Grow Brighter
    • Predictive Diagnostics - Crucial for Breast Cancer Management
    • Inherited Breast Cancer - An Important End-use Market for Predictive Diagnostics
    • Oncology: A Key Growth Driver for Predictive Diagnostics
    • Genes and Associated Cancers/Tumors
    • Increasing Incidence of Colorectal Cancer in <50 Age Group: A Business Case for Predictive Diagnostics
    • Growing Number of Colorectal Cancer Risk Population with Lynch Syndrome
    • Launch of PromarkerD: Hope for Early Diagnosis of Diabetic Kidney Disease
    • What is PromarkerD?
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Predictive Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Predictive Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 3: World 16-Year Perspective for Predictive Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2023 & 2030
    • TABLE 4: World Predictive Diagnostics Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Predictive Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
    • TABLE 5: USA Recent Past, Current & Future Analysis for Predictive Diagnostics by Segment - Predictive Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 6: USA Historic Review for Predictive Diagnostics by Segment - Predictive Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • CANADA
    • TABLE 7: Canada Recent Past, Current & Future Analysis for Predictive Diagnostics by Segment - Predictive Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 8: Canada Historic Review for Predictive Diagnostics by Segment - Predictive Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • JAPAN
    • Predictive Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
    • TABLE 9: Japan Recent Past, Current & Future Analysis for Predictive Diagnostics by Segment - Predictive Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 10: Japan Historic Review for Predictive Diagnostics by Segment - Predictive Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • CHINA
    • Predictive Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
    • TABLE 11: China Recent Past, Current & Future Analysis for Predictive Diagnostics by Segment - Predictive Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 12: China Historic Review for Predictive Diagnostics by Segment - Predictive Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • EUROPE
    • Predictive Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
    • TABLE 13: Europe Recent Past, Current & Future Analysis for Predictive Diagnostics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 14: Europe Historic Review for Predictive Diagnostics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 15: Europe 16-Year Perspective for Predictive Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2023 & 2030
  • FRANCE
    • Predictive Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
    • TABLE 16: France Recent Past, Current & Future Analysis for Predictive Diagnostics by Segment - Predictive Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 17: France Historic Review for Predictive Diagnostics by Segment - Predictive Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • GERMANY
    • Predictive Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
    • TABLE 18: Germany Recent Past, Current & Future Analysis for Predictive Diagnostics by Segment - Predictive Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 19: Germany Historic Review for Predictive Diagnostics by Segment - Predictive Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • ITALY
    • TABLE 20: Italy Recent Past, Current & Future Analysis for Predictive Diagnostics by Segment - Predictive Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 21: Italy Historic Review for Predictive Diagnostics by Segment - Predictive Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • UNITED KINGDOM
    • Predictive Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
    • TABLE 22: UK Recent Past, Current & Future Analysis for Predictive Diagnostics by Segment - Predictive Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 23: UK Historic Review for Predictive Diagnostics by Segment - Predictive Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • REST OF EUROPE
    • TABLE 24: Rest of Europe Recent Past, Current & Future Analysis for Predictive Diagnostics by Segment - Predictive Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 25: Rest of Europe Historic Review for Predictive Diagnostics by Segment - Predictive Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • ASIA-PACIFIC
    • Predictive Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
    • TABLE 26: Asia-Pacific Recent Past, Current & Future Analysis for Predictive Diagnostics by Segment - Predictive Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 27: Asia-Pacific Historic Review for Predictive Diagnostics by Segment - Predictive Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • REST OF WORLD
    • TABLE 28: Rest of World Recent Past, Current & Future Analysis for Predictive Diagnostics by Segment - Predictive Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 29: Rest of World Historic Review for Predictive Diagnostics by Segment - Predictive Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR

IV. COMPETITION